{
    "clinical_study": {
        "@rank": "48497", 
        "arm_group": {
            "arm_group_label": "Use of a bowel irrigation system", 
            "arm_group_type": "Other", 
            "description": "Open label. No placebo use in this study. All volunteers will trial the bowel irrigation system. Eligible volunteers will be those patients who have failed conventional supportive bowel care."
        }, 
        "brief_summary": {
            "textblock": "To compare the Peristeen Anal Irrigation System with conservative bowel management in a\n      prospective study among spinal cord injured patients with lower motor neuron neurogenic\n      bowel dysfunction."
        }, 
        "brief_title": "Peristeen Bowel Irrigation System in Cauda Equina", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cauda Equina Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Glanders", 
                "Polyradiculopathy"
            ]
        }, 
        "detailed_description": {
            "textblock": "People with spinal cord injury (SCI) often have severe problems with management of bowel\n      function, including incontinence, impaction, lengthy bowel routines and extremely slow\n      transit times.The anal irrigation system is a recently available system to help patients\n      with bowel dysfunction empty their bowels by using pulse water irrigation. The system\n      consists of a rectal balloon catheter, manual pump and water container."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female >18 years or older\n\n          -  Cauda equina spinal injury at least 12 months previously, with lower motor neuron\n             bowel dysfunction and at least one of the following symptoms:\n\n          -  Spending 30 minutes or more attempting to defecate each day or every second day\n\n          -  Episodes of fecal incontinence once or more per month\n\n          -  Abdominal discomfort before or during defecation\n\n        Exclusion Criteria:\n\n          -  Coexisting major unresolved physical problems due to the injury\n\n          -  Performance of transanal irrigation on a regular basis\n\n          -  Evidence of bowel obstruction or active inflammatory bowel disease\n\n          -  History of cerebral palsy, stroke, multiple sclerosis or diabetic polyneuropathy\n\n          -  Previous colorectal or perineal surgery(excluding minor surgery such as\n             hemorrhoidectomy)\n\n          -  Pregnancy or lactation\n\n          -  Immunosuppression\n\n          -  Prior implant for sacral nerve stimulation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01784328", 
            "org_study_id": "2013"
        }, 
        "intervention": {
            "arm_group_label": "Use of a bowel irrigation system", 
            "description": "A complete system for bowel Irrigation to manage bowel dysfunction", 
            "intervention_name": "Peristeen Bowel Irrigation System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Peristeen Bowel Irrigation System", 
            "Cauda Equina Syndrome", 
            "Lower Motor Neuron Neurogenic Bowel"
        ], 
        "lastchanged_date": "June 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Winnipeg", 
                    "country": "Canada", 
                    "state": "Manitoba", 
                    "zip": "R3A 1M4"
                }, 
                "name": "WRHA Health Sciences Centre Rehabilitation Hospital"
            }, 
            "investigator": {
                "last_name": "Alan Casey, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Use of the Peristeen Bowel Irrigation System for People With Cauda Equina Syndrome", 
        "overall_contact": {
            "email": "tolafson@hsc.mb.ca", 
            "last_name": "Tracey Olafson, RN", 
            "phone": "(204) 787-2725"
        }, 
        "overall_official": {
            "affiliation": "University of Manitoba", 
            "last_name": "Karen Ethans, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "A scoring system with a range of 0-30, with 30 representing the most severe symptoms. Will be used for volunteers whose primary complaint at baseline is constipation.", 
                "measure": "Change from baseline on Cleveland Clinic Constipation Scoring System after 10 weeks of treatment", 
                "safety_issue": "No", 
                "time_frame": "At baseline Visit and again after 10 weeks of treatment"
            }, 
            {
                "description": "A Grading system with a range of 0-24, with 24 representing the most severe symptoms. This will be used for volunteers whose primary complaint at baseline is fecal incontinence.", 
                "measure": "Change from baseline on the St. Mark's Fecal Incontinence Grading System after 10 weeks of treatment.", 
                "safety_issue": "No", 
                "time_frame": "At baseline and again after 10 weeks of treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01784328"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Manitoba", 
            "investigator_full_name": "Dr. Karen Ethans", 
            "investigator_title": "Director, Spinal Cord Injury Rehabilitation Program", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "A symptom score ranging from 0-47, where each symptom of neurogenic bowel is weighted concerning it's impact on quality of life. A score of 47 represents severe symptoms.", 
                "measure": "Change from baseline in  The Neurogenic Bowel Dysfunction Score after 10 weeks of treatment", 
                "safety_issue": "No", 
                "time_frame": "At baseline and again after 10 weeks of treatment"
            }, 
            {
                "description": "Symptom-related Quality of Life Score", 
                "measure": "Change from baseline in a modified American Society of Colon and Rectal Surgeons fecal incontinence score after 10 weeks of treatment.", 
                "safety_issue": "No", 
                "time_frame": "At baseline and again after 10 weeks of treatment"
            }, 
            {
                "description": "The Metcalf method will be used.At the screening visit,eligible volunteers will be given a 7-day bowel diary and 3 SitzMark capsules with instructions on how to complete the diary and when to take the capsules. Abdominal X-rays will be obtained on Day 4 and 7. The patient will repeat the diary, SitzMark capsules and X-rays during the last week of study treatment.", 
                "measure": "Change from baseline measurement of Colonic Transit Time (CTT)after 10 weeks of treatment", 
                "safety_issue": "No", 
                "time_frame": "At baseline and again after 10 weeks of treatment."
            }, 
            {
                "description": "Numeric box scales with a range of 1-10", 
                "measure": "Change from baseline on a numeric box scale to measure bowel function, influence on daily activities, and general satisfaction after 10 weeks of treatment.", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 10 weeks of treatment."
            }, 
            {
                "description": "A numeric box scale with a range of 0-10, with 0 representing great reduction and 10 representing great improvement.", 
                "measure": "Measurement of Influence of Current Bowel Management on Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "After 10 weeks of treatment"
            }
        ], 
        "source": "University of Manitoba", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Manitoba Spinal Cord Injury Research Committee", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "C/O Canadian Paraplegic Association, MB Inc", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Manitoba", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}